Standard Care | Low Risk

MENTHOL 4% (DCH Cooling Pain Relief)

What to know about MENTHOL 4% — also sold as DCH Cooling Pain Relief: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

MENTHOL 4% (brand names: DCH Cooling Pain Relief) is classified as Low risk (1 risk points) by AllMeds. It is a S2 medication under the TGA in Australia. FDA approved in the United States. Lower concentration menthol topical with mild local counterirritant effects.

Key Takeaways

  • TGA Schedule: S2 in Australia
  • Risk level: Low (1 points)

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S2 Not PBS listed
United States (FDA) Rx only FDA approved

Risk Profile

Risk Level Low
Risk Points 1
CNS Depressant No
Respiratory Risk No

Lower concentration menthol topical with mild local counterirritant effects.

How MENTHOL 4% is regulated

MENTHOL 4% is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Australia TGA / PBS / State Schemes

Classified as S2 under the Therapeutic Goods Administration (TGA).

United States FDA / CDC / State WC

FDA approved for use in the United States.

Check this medication against your full medication list

Run a full risk assessment including MENTHOL 4% interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.